High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 10, Pages e75677
Publisher
Public Library of Science (PLoS)
Online
2013-10-05
DOI
10.1371/journal.pone.0075677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Human Papillomavirus (HPV)In VitroNeutralization Assay That Recapitulates theIn VitroProcess of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies
- (2012) Patricia M. Day et al. Clinical and Vaccine Immunology
- High-throughput SNP-based authentication of human cell lines
- (2012) Felipe Castro et al. INTERNATIONAL JOURNAL OF CANCER
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine
- (2011) Francis J. Dessy et al. Human vaccines & immunotherapeutics
- A Competitive Serological Assay Shows Naturally Acquired Immunity to Human Papillomavirus Infections in the Guanacaste Natural History Study
- (2011) Nicolas Wentzensen et al. JOURNAL OF INFECTIOUS DISEASES
- A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection
- (2011) S. Longet et al. JOURNAL OF VIROLOGY
- The first international standard for antibodies to HPV 16
- (2011) Morag Ferguson et al. VACCINE
- Vaccines to Prevent Infections by Oncoviruses
- (2010) John T. Schiller et al. Annual Review of Microbiology
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
- (2010) Ivonne Rubio et al. VIROLOGY
- HPV Vaccines: Preclinical Development
- (2009) Lutz Gissmann ARCHIVES OF MEDICAL RESEARCH
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- High-throughput detection and multiplex identification of cell contaminations
- (2009) M. Schmitt et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation